Migraine attacks were more frequent in post-pubertal compared to pre-pubertal girls, with no observed difference in headache characteristics between the groups.
Researchers evaluated sensory function in the trigeminocervical region in patients with cluster headache, migraine headache, and tension-type headache.
The FDA has approved Elyxyb an oral solution formulation of celecoxib, for the acute treatment of migraine with or without aura in adults.
Yoga plus medical care is better than medical therapy alone for the treatment of episodic migraines.
Repetitive multiple cranial nerve blocks may offer a clinically meaningful benefit as a preventative measure in patients with chronic migraine.
Study findings suggest that pain modulation may be impaired in patients with migraine in the headache-free interval, despite an unaffected sensory profile.
Fremanezumab is now available in an autoinjector device for the preventive treatment of migraine in adults.
Children, adolescents, and young adults with status migrainosus have distinct clinical features and an unfavorable short-term prognosis.
Repetitive dosing with valproate sodium is safe, well tolerated, and possibly effective for managing headache in patients with chronic migraine.
In patients with episodic migraines, the occurrence of a migraine headache does not consistently impact nighttime sleep.